Waters Co. (WAT) SVP Terrence P. Kelly Sells 8,997 Shares

Waters Co. (NYSE:WAT) SVP Terrence P. Kelly sold 8,997 shares of the company’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $173.59, for a total transaction of $1,561,789.23. Following the sale, the senior vice president now owns 11,464 shares of the company’s stock, valued at $1,990,035.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, April 25th. The medical instruments supplier reported $1.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.33 by $0.13. Waters had a net margin of 24.06% and a return on equity of 24.47%. The company had revenue of $497.97 million during the quarter, compared to analysts’ expectations of $489.37 million. During the same period in the prior year, the company posted $1.26 earnings per share. Waters’s revenue for the quarter was up 4.8% compared to the same quarter last year.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

TRADEMARK VIOLATION NOTICE: This piece was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/05/20/terrence-p-kelly-sells-8997-shares-of-waters-co-wat-stock-updated.html.

Several large investors have recently bought and sold shares of WAT. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its position in shares of Waters by 2.8% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 13,634 shares of the medical instruments supplier’s stock valued at $2,161,000 after buying an additional 368 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Waters by 1.4% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 231,509 shares of the medical instruments supplier’s stock valued at $36,692,000 after buying an additional 3,249 shares in the last quarter. Rothschild Asset Management Inc. raised its position in shares of Waters by 15.9% in the third quarter. Rothschild Asset Management Inc. now owns 3,179 shares of the medical instruments supplier’s stock valued at $504,000 after buying an additional 436 shares in the last quarter. World Asset Management Inc raised its position in shares of Waters by 1.7% in the third quarter. World Asset Management Inc now owns 8,081 shares of the medical instruments supplier’s stock valued at $1,281,000 after buying an additional 138 shares in the last quarter. Finally, Mcdonald Capital Investors Inc. CA raised its position in shares of Waters by 5.4% in the third quarter. Mcdonald Capital Investors Inc. CA now owns 166,519 shares of the medical instruments supplier’s stock valued at $26,392,000 after buying an additional 8,496 shares in the last quarter. Institutional investors own 92.53% of the company’s stock.

Several research firms recently weighed in on WAT. Cowen and Company increased their target price on shares of Waters from $160.00 to $175.00 and gave the company a “market perform” rating in a research note on Wednesday, April 26th. Barclays PLC set a $160.00 target price on shares of Waters and gave the company a “hold” rating in a research note on Wednesday, April 26th. Janney Montgomery Scott upgraded shares of Waters from a “neutral” rating to a “buy” rating and raised their price target for the stock from $185.00 to $200.00 in a research note on Monday, May 1st. Deutsche Bank AG restated a “buy” rating and set a $183.00 price target (up previously from $166.00) on shares of Waters in a research note on Saturday, April 29th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $190.00 price target (up previously from $170.00) on shares of Waters in a research note on Tuesday, April 25th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $168.91.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

12 Month Chart for NYSE:WAT

Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply